Skip to main navigation Skip to search Skip to main content

Effects of a transdiagnostic group treatment for anxiety on secondary depression

Research output: Contribution to journal › Article › Research › peer-review

Abstract

Researchers have recently explored transdiagnostic anxiety treatments based on models of anxiety emphasizing a single common pathway across diagnostic categories. Results from a previous study [Norton and Hope, in press] indicated that a transdiagnostic approach was effective for both targeted and untargeted anxiety disorders. Consistent with the tripartite model, the transdiagnostic treatment should also influence symptoms of a broader pathology such as negative affectivity. This follow-up to Norton and Hope found significant decreases in depressed mood for clients undergoing transdiagnostic treatment for anxiety when compared to wait-list control participants. Although not statistically established, severity of depressive diagnoses seemed to generally decrease across treatment, whereas no change in severity occurred for those not receiving treatment.
Original languageEnglish
Pages (from-to)198-202
JournalDepression and Anxiety
Volume20
Issue number4
DOIs
Publication statusPublished - 2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Effects of a transdiagnostic group treatment for anxiety on secondary depression'. Together they form a unique fingerprint.

Cite this